Madrigal Pharmaceuticals, Inc. (MDGL)
501.68
+5.80
(+1.17%)
USD |
NASDAQ |
Jan 16, 16:00
501.64
-0.04
(-0.01%)
After-Hours: 20:00
Madrigal Pharmaceuticals EPS Diluted (Quarterly): -5.079 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Eli Lilly & Co. | 6.211 |
| Amgen, Inc. | 5.934 |
| Crinetics Pharmaceuticals, Inc. | -1.381 |
| Amicus Therapeutics, Inc. | 0.0558 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -114.19M |
| Revenue (Quarterly) | 287.27M |
| Total Expenses (Quarterly) | 401.46M |
| Enterprise Value | 10.63B |
| Gross Profit Margin (Quarterly) | 93.57% |
| Profit Margin (Quarterly) | -39.75% |
| Earnings Yield | -2.59% |
| Normalized Earnings Yield | -2.576 |